Sun Pharma Adv. Res Share Price

Sun Pharma Adv. Res (INR)209.29-6.3   (-2.9%)

Exchange ScripsBSE532872NSESPARCISININE232I01014

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Sun Pharma Adv. Res Performance

Market performance
Open price217
High218.2
Volumes1071841
Prev Close209.29
Low207.74
Closing date2024-10-21
Historical performance
1 Year High472.80
3 Year High472.80
5 Year High472.80
1 Year Low196.10
3 Year Low162.10
5 Year Low81.00

Sun Pharma Adv. Res Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
7001
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
-17.5
Dividend Yield
Dividend Yield
N/A

Sun Pharma Adv. Res Investment Returns

1 Year
-10.4%
3 Years
-26.3%
5 Years
58%
10 Years
11.8%

Sun Pharma Adv. Res Technicals

IndicatorsValueSignal
5-DMA212.26Bearish
10-DMA210.94Bearish
20-DMA212.05Bearish
50-DMA218.09Bearish
100-DMA223.53Bearish
200-DMA280.89Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1414141414
Foreign Investors---------------
Domestic Investors1414141414
Public Investors128191125170102729103976101419
Government11111

Sun Pharma Adv. Res Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Sales------
Operating Expenses14021803
Other Income295109
Operating Profit-3726-2032
Interest1776
Depreciation125118
Profit Before Tax-3868-2226
Consolidated Net Profit-3872-2226
Adjusted EPS-12-7

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Share Capital325325
Total Reserves9334803
Minority Interest------
Total Non-Current Liabilities12301384
Total Liabilities51388301
Capital Work in Progress1319
Total Assets51388301

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Cash Flow from Operating Activities-4292-691
Cash Flow from Investing Activities3915-5483
Cash Flow from Financing Activitie4246168
Net Cash Inflow / Outflow47-6
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -17.5.
  • 3Y Stock Price CAGR of the stock is -9.7.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹-3743 Million.
  • The company generated revenue of ₹755 Million in the previous financial year.

Sun Pharma Adv. Res

209.29-6.3   (-2.9%)

Investment Amount: ₹ 22230
Current Value: ₹ 20929
Performence: -5.9%
P/L: ₹ -1301
Top Gainers
SymbolChange%
VHL5303.9(20%)
GFLLIMITED119.34(20%)
DIFFNKG408.3(20%)
SILINV877.1(20%)
PILANIINVS7536.05(20%)
Top Losers
SymbolChange%
PNCINFRA366.8(-20%)
INDIAMART2508.6(-17%)
RBLBANK176.14(-14%)
WABAG1710(-9%)
JMFINANCIL147.05(-7%)
MITCON107.19(-7%)
TATACONSUM1017.05(-7%)
AETHER862.6(-7%)
Similar stocks

Future MarketNetwork

20

13.44

September 21 - October 21

Crown Lifters

2.3

244.65

September 21 - October 21

Latent View Analytic

0.3

478.85

September 21 - October 21

Just Dial

-1.6

1162.95

September 21 - October 21

PTL Enterprises

-3

42.43

September 21 - October 21

RK Swamy

-3.5

245.89

September 21 - October 21

Krystal Integrated

-6

721.8

September 21 - October 21

Syngene Internation.

-6

855.15

September 21 - October 21

Announcing Stock of the Month!

Stock of the Month
Stock of the Month